Leila Farahmand

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 14

Top Topics

Tyrosine Kinase

Escherichia Coli

Epithelial Mesenchymal Transition

Top Venues

Cancer cell international

Journal of biological engineering

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Ebrahim Khodaverdi, Ali Akbar Shabani, Hamid Madanchi, Leila Farahmand
Synthesis of the scFv fragment of anti-Frizzled-7 antibody and evaluation of its effects on triple-negative breast cancer in vitro study. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Soodabeh Shafiee, Roya Mirzaei, Malihe Salehi, Neda Jalili, Amir Taheri, Leila Farahmand
Synthesized Anti-HER2 Trastuzumab-MCC-DM1 Conjugate: An Evaluation of Efficacy and Cytotoxicity. Iranian journal of immunology : IJI 20 (3) (2023)
Mitra Samadi, Laleh Beigi, Fatemeh Yadegari, Alireza Madjid Ansari, Keivan Majidzadeh-A, Maryam Eskordi, Leila Farahmand
Recognition of functional genetic polymorphism using ESE motif definition: a conservative evolutionary approach to CYP2D6/CYP2C19 gene variants. Genetica 150 (5) (2022)
Khadijeh Barzaman, Rana Vafaei, Mitra Samadi, Mohammad Hossein Kazemi, Aysooda Hosseinzadeh, Parnaz Merikhian, Shima Moradi-Kalbolandi, Mohammad Reza Eisavand, Houra Dinvari, Leila Farahmand
Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk. Cancer cell international 22 (1) (2022)
Behrad Darvishi, Mohammad Reza Eisavand, Keivan Majidzadeh-A, Leila Farahmand
Matrix stiffening and acquired resistance to chemotherapy: concepts and clinical significance. British journal of cancer 126 (9) (2022)
Rana Vafaei, Mitra Samadi, Aysooda Hosseinzadeh, Khadijeh Barzaman, MohammadReza Esmailinejad, Zohreh Khaki, Leila Farahmand
Comparison of mucin-1 in human breast cancer and canine mammary gland tumor: a review study. Cancer cell international 22 (1) (2022)
Aysooda Hosseinzadeh, Parnaz Merikhian, Nazanin Naseri, Mohammad Reza Eisavand, Leila Farahmand
MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy. Cancer cell international 22 (1) (2022)
Parnaz Merikhian, Mohammad Reza Eisavand, Leila Farahmand
Triple-negative breast cancer: understanding Wnt signaling in drug resistance. Cancer cell international 21 (1) (2021)
Mitra Samadi, Keivan Majidzadeh-A, Malihe Salehi, Neda Jalili, Zeinab Noorinejad, Marjan Mosayebzadeh, Ahad Muhammadnejad, Azadeh Sharif Khatibi, Shima Moradi-Kalbolandi, Leila Farahmand
Engineered hypoxia-responding Escherichia coli carrying cardiac peptide genes, suppresses tumor growth, angiogenesis and metastasis in vivo. Journal of biological engineering 15 (1) (2021)
Parnaz Merikhian, Behrad Darvishi, Neda Jalili, Mohammad Reza Esmailinejad, Azadeh Sharif Khatibi, Shima Moradi Kalbolandi, Malihe Salehi, Marjan Mosayebzadeh, Mahdieh Shokrollahi Barough, Keivan Majidzadeh-A, Fatemeh Yadegari, Fatemeh Rahbarizadeh, Leila Farahmand
Recombinant nanobody against MUC1 tandem repeats inhibits growth, invasion, metastasis, and vascularization of spontaneous mouse mammary tumors. Molecular oncology (2021)
Sepideh Mansouri, Parisa Mokhtari-Hesari, Fatemeh Naghavi-Al-Hosseini, Seyed Afshin Seyednejad, Keivan Majidzadeh-A, Shima Moradi-Kalbolandi, Marziyeh Ghahremanlou, Leila Farahmand
Evaluating human epidermal growth factor receptor 2 roles in the efficacy of Tamoxifen treatment in breast cancer, a systematic review. Pharmacological reports : PR 73 (2) (2021)
Farnaz Khodabakhsh, Parnaz Merikhian, Mohammad Reza Eisavand, Leila Farahmand
Crosstalk between MUC1 and VEGF in angiogenesis and metastasis: a review highlighting roles of the MUC1 with an emphasis on metastatic and angiogenic signaling. Cancer cell international 21 (1) (2021)
Behrad Darvishi, Malihe Salehi, Saeedeh Boroumandieh, Keivan Majidzadeh-A, Neda Jalili, Shima Moradi-Kalbolandi, Leila Farahmand
Dual in vitro invasion/migration suppressing and tamoxifen response modulating effects of a recombinant anti-ALCAM scFv on breast cancer cells. Cell biochemistry and function 38 (5) (2020)
Mohadeseh Haji Abdolvahab, Behrad Darvishi, Mohadeseh Haji Abdolvahab, Keivan Majidzadeh-A, Leila Farahmand
Interferons: role in cancer therapy. Immunotherapy 12 (11) (2020)